CDKN3 and prostate cancer: Similarly, cyclin dependent kinase inhibitor 3 (CDKN3) is overexpressed in prostate cancer, and its inhibition enhances apoptosis and promotes G1 cell cycle arrest by reducing the expression of cell cycle and DNA replication proteins, inhibiting cancer cell growth and invasion [22].